Gerresheimer AG (GXI) - Cash Flow Conversion Efficiency

Latest as of May 2025: 0.042x

Based on the latest financial reports, Gerresheimer AG (GXI) has a cash flow conversion efficiency ratio of 0.042x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.03 Million ≈ $72.51 Million USD) by net assets (€1.47 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GXI net asset quality index to measure how much of total assets are equity-financed.

Gerresheimer AG - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Gerresheimer AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Gerresheimer AG (GXI) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Gerresheimer AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gerresheimer AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Doman Building Materials Group Ltd
TO:DBM
-0.206x
Qingdao Hiron Commercial Cold Chain Co Ltd
SHG:603187
0.074x
Transcat Inc
NASDAQ:TRNS
0.041x
SK Securities Co Ltd Preference Shares
KO:001515
-0.069x
Bumi Serpong Damai Tbk
JK:BSDE
-0.009x
Shandong Jincheng Pharmaceutical and Chemical Co Ltd
SHE:300233
0.021x
Taihe Technologies
SHE:300801
0.033x
LSI Industries Inc
NASDAQ:LYTS
0.101x

Annual Cash Flow Conversion Efficiency for Gerresheimer AG (2013–2024)

The table below shows the annual cash flow conversion efficiency of Gerresheimer AG from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Gerresheimer AG stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-11-30 €1.54 Billion
≈ $1.80 Billion
€240.33 Million
≈ $280.97 Million
0.156x -21.89%
2023-11-30 €1.47 Billion
≈ $1.72 Billion
€294.34 Million
≈ $344.11 Million
0.200x +14.34%
2022-11-30 €1.27 Billion
≈ $1.48 Billion
€221.94 Million
≈ $259.47 Million
0.175x -17.37%
2021-11-30 €1.00 Billion
≈ $1.17 Billion
€212.08 Million
≈ $247.94 Million
0.212x -14.32%
2020-11-30 €899.66 Million
≈ $1.05 Billion
€222.19 Million
≈ $259.77 Million
0.247x +20.53%
2019-11-30 €941.56 Million
≈ $1.10 Billion
€192.92 Million
≈ $225.55 Million
0.205x +5.14%
2018-11-30 €890.13 Million
≈ $1.04 Billion
€173.47 Million
≈ $202.81 Million
0.195x -29.79%
2017-11-30 €789.52 Million
≈ $923.04 Million
€219.16 Million
≈ $256.22 Million
0.278x +22.13%
2016-11-30 €763.29 Million
≈ $892.37 Million
€173.49 Million
≈ $202.82 Million
0.227x -22.13%
2015-11-30 €698.13 Million
≈ $816.19 Million
€203.78 Million
≈ $238.24 Million
0.292x +11.45%
2014-11-30 €604.37 Million
≈ $706.57 Million
€158.29 Million
≈ $185.05 Million
0.262x +0.60%
2013-11-30 €563.40 Million
≈ $658.68 Million
€146.68 Million
≈ $171.48 Million
0.260x --

About Gerresheimer AG

F:GXI Germany Medical Instruments & Supplies
Market Cap
$1.12 Billion
€958.14 Million EUR
Market Cap Rank
#10220 Global
#1235 in Germany
Share Price
€27.74
Change (1 day)
-6.85%
52-Week Range
€15.51 - €46.30
All Time High
€120.00
About

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, a… Read more